This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Daniel Sejer Pedersen, PhD
Chemical Development Specialist, Chemical Development at Novo Nordisk
Speaker

Profile

Daniel Sejer Pedersen obtained his PhD degree in synthetic organic chemistry from Cambridge University in 2005 and has held a variety of positions at universities and in industry. Since 2018 he has been employed in Chemical Development at Novo Nordisk working on synthetic phase 3 projects and the assessment and development of new manufacturing technologies.

Agenda Sessions

  • Towards Greener Peptide Production for Phase 3 and Market

    16:00